Proactive Formed for Cancer Biomarker Platform
A new European consortium has been formed to develop a platform for detecting protein-based disease biomarkers.
Called Proactive, the consortium comprises six industry and academic institution partners and is coordinated by Olink Bioscience, based in Uppsala, Sweden.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
